In contrast, HGBL‐MYC/BCL6 was removed as a separate entity in the current WHO‐5th classification, and cases are now included as a subtype of DLBCL, NOS, or HGBL, NOS depending on morphologic criteria. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.